Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-04

Clinical Trial Update: Study of Cannabidiol for Drug-Resistant Epilepsies

View source ↗

Summary

This clinical trial update notes that cannabidiol for drug-resistant epilepsies is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Eric Marsh, MD | Conditions: Drug Resistant Epilepsy | Status: NO_LONGER_AVAILABLE